Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child
Ozdemir, H.; Ciftçi, E.; Karbuz, A.; Oktay, G.ül.şa.; Aysev, D.; Yavuz, G.ül.; Ince, E.
Turkish Journal of Pediatrics 54(1): 59-60
2012
ISSN/ISBN: 0041-4301 PMID: 22397044 Document Number: 657016
The multidrug-resistant bacterial infections cause high mortality in immunocompromised patients because of the limited antibacterial choices. Tigecycline, first member of the glycylcyclines, has in vitro activity against a wide variety of organisms, including multidrug-resistant pathogens; however, it has not yet been approved for use in children. Herein, we report a nine-year-old girl with acute myeloid leukemia who was treated successfully with tigecycline due to multidrug-resistant Escherichia coli bacteremia.